Propulsid Quicksolv is a drug owned by Janssen Pharmaceutica Products Lp. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jul 15, 2014. Details of Propulsid Quicksolv's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5648093 | Pharmaceutical and other dosage forms |
Jul, 2014
(10 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Propulsid Quicksolv is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Propulsid Quicksolv's family patents as well as insights into ongoing legal events on those patents.
Propulsid Quicksolv's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Propulsid Quicksolv's generic launch date based on the expiry of its last outstanding patent is estimated to be Jul 15, 2014 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Propulsid Quicksolv Generics:
There are no approved generic versions for Propulsid Quicksolv as of now.
About Propulsid Quicksolv
Propulsid Quicksolv is a drug owned by Janssen Pharmaceutica Products Lp. Propulsid Quicksolv uses Cisapride Monohydrate as an active ingredient. Propulsid Quicksolv was launched by Janssen Pharma in 1997.
Approval Date:
Propulsid Quicksolv was approved by FDA for market use on 07 November, 1997.
Active Ingredient:
Propulsid Quicksolv uses Cisapride Monohydrate as the active ingredient. Check out other Drugs and Companies using Cisapride Monohydrate ingredient
Dosage:
Propulsid Quicksolv is available in tablet, orally disintegrating form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 20MG BASE | TABLET, ORALLY DISINTEGRATING | Discontinued | ORAL |